This message was sent to ##Email##
|
| October 11, 2017 |
| |  | | |
|
|
|
| |
Genome Web
Lab industry stakeholders are expressing concerns over new draft recommendations for cervical cancer screening, saying they may be difficult to implement. Recently, the U.S. Preventative Services Task Force issued draft recommendations saying women aged 30 to 65 can be screened for cervical cancer either every three years using a Pap smear, or every five years with high risk human papillomavirus testing alone.
READ MORE
| ASCT's response to the USPSTF draft guidelines
|
    |
ASCT
ASCT recently worked with the other member organizations of the Cytotechnology Education and Technology Consortium (CETC) to respond to the draft guidelines for cervical cancer screening that were recently released by the United States Preventative Services Task Force (USPSTF). The text of that letter can be seen here. We would like thank those of you who took the time to send in your own individual responses during the public comment period. Our hope is that the USPSTF will take our concerns into consideration as they finalize their recommendations.
 |
|
Surgilube® has been the preferred sterile lubricant in the medical community since 1932. It is the only sterile carbomer-free lubricant preferred by Hologic® for use with the ThinPrep® Pap test. Surgilube® has undergone stringent and periodic testing by Hologic® and met established quality parameters without impacting ThinPrep® Pap test results.
|
|
| Date |
Event |
Location |
More information |
Jan. 17, 2018 |
Quantitative Cytology and its Emerging Role in Daily Practice
|
Your PC |
Liron Pantanowitz, MD
Professor of Pathology & Biomedical Informatics
Director of Pathology Informatics
Director of Cytopathology UPMC Shadyside
Director of Pathology Informatics Fellowship
Department of Pathology, UPMC Shadyside
Pittsburgh, PA
Details
|
June 20, 2018 |
The Bethesda System for Cervical Cytology — Update and Beyond
|
Your PC |
Patricia G. Tiscornia-Wasserman, MD
Professor of Pathology and Cell Biology
Director of Cytopathology
Columbia University Medical Center
Melville, New York
Details
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
CAP Today
The CAP has focused during the past 10 years on facilitating the transformation of pathology practices from the instrumentation age to the information age, with a concentration on personalized medical care and laboratorians as integral members of the health care team. Hand-in-hand with that effort, the CAP Cytopathology Committee has advocated for the expanded use of cytology specimens in molecular diagnostics and the evolution of the cytotechnology workforce to meet the emerging practice gaps as pathologists become engaged in ever more complex diagnostic processes.
READ MORE
Medical News Today
New research from Georgetown University in Washington, D.C., investigates how the human papillomavirus promotes cancer. The findings might point to a potential new and improved strategy for targeted treatment. The study, which was led by Dr. Xuefeng Liu, describes a molecular apparatus that renders cancer cells "immortal." Understanding how this apparatus works may lead to better targeted treatments in the future, the researcher suggests.
READ MORE
Reuters
Many women with early-stage breast cancer have full-time jobs when they're diagnosed, and they are more likely to miss at least a month of work when they receive aggressive treatment that includes surgery, a U.S. study suggests.
READ MORE
Medical Xpress
Ewing sarcomas — rare, aggressive childhood cancers — are derived from mesenchymal cells in bone and soft tissues, and children with metastatic disease have poor survival. In a search for new therapeutic options for Ewing sarcoma, Dai Chung, M.D., and colleagues tested a compound previously identified at Vanderbilt, ML327, that induces the expression of the cell adhesion protein E-cadherin. E-cadherin, a hallmark of epithelial cells, is often lost as cancer cells become invasive. Its re-expression in epithelial cancers blocks cell invasiveness.
READ MORE
Infectious Disease Advisor
Hepatocellular carcinoma is the third cause of cancer-related death and accounts for more than 90 percent of primary liver cancers. It is most frequently diagnosed at an advanced stage in patients with chronic liver injury and cirrhosis. Despite dedicated research in the last few decades, significant advancements in the treatment of HCC have not been achieved, and HCC still belongs to the category of cancers with a very low 5-year survival rate of less than 20 percent.
READ MORE
Medical Xpress
Scientists at Albert Einstein College of Medicine have discovered the first compound that directly makes cancer cells commit suicide while sparing healthy cells. The new treatment approach, described in today's issue of Cancer Cell, was directed against acute myeloid leukemia cells but may also have potential for attacking other types of cancers.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
